Type / Class
Equity / Ordinary Shares, par value $0.000174 per share
Shares outstanding
62,779,302
Total 13F shares
2,944,726
Share change
+70,543
Total reported value
$4,229,340
Price per share
$1.44
Number of holders
11
Value change
+$101,251
Number of buys
4
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BML Capital Management, LLC
13F
Company
3.3%
2,043,248
$3,105,737 30 Jun 2024
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.81%
510,701
$776,266 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.34%
212,300
$322,696 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
0.17%
103,891
$157,914 30 Jun 2024
13F
Keudell/Morrison Wealth Management
13F
Company
0.05%
32,200
$48,944 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
27,961
$42,500 30 Jun 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.03%
20,000
$30,000 30 Jun 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.02%
12,700
$19,000 30 Jun 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
9,500
$14,439 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.01%
3,568
$5,423 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0%
121
$184 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
46
$70 30 Jun 2024
13F

Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q3 2024

As of 30 Sep 2024, Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,944,726 shares. The largest 10 holders included BML Capital Management, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), RENAISSANCE TECHNOLOGIES LLC, Callan Capital, LLC, Keudell/Morrison Wealth Management, Royal Bank of Canada, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, RHUMBLINE ADVISERS, and BlackRock, Inc.. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
12
Q3 2024 holders
11
Holder diff
-1
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .